Treating Primary Sclerosing Cholangitis: Current Approaches and Future Possibilities
Published: Mar 13, 2024
Primary sclerosing cholangitis (PSC) is a challenging liver disease to treat. While there's no cure yet, several approaches can help manage symptoms and slow progression.
Contents
Medical Treatments
Ursodeoxycholic acid (UDCA) is often prescribed to improve liver function, though its long-term benefits are debated. Other medications may be used to manage specific symptoms like itching or infections. Immunosuppressants have been studied but haven't shown clear benefits for most patients. Emerging therapies targeting inflammation and fibrosis are under investigation.
Endoscopic Procedures
For patients with dominant strictures (severely narrowed bile ducts), endoscopic procedures can help. Balloon dilation or temporary stent placement can open up blocked ducts, improving bile flow and reducing symptoms. These procedures may need to be repeated periodically as strictures can recur.

Liver Transplantation
For advanced PSC, liver transplantation is the only curative option. Outcomes are generally good, with 5-year survival rates around 85%. However, PSC can recur in the transplanted liver in some cases. Patients need lifelong immunosuppression after transplant.
Managing Complications
PSC increases the risk of certain cancers, so regular screening is crucial. This includes colonoscopies for colorectal cancer and imaging studies to check for bile duct cancer. Osteoporosis is another concern, so bone density scans and calcium/vitamin D supplements may be recommended.
Frequently Asked Questions
No specific diet is proven, but a healthy, balanced diet is recommended.
Some patients try supplements, but effectiveness is unproven.
Usually every 3-6 months, or more if symptoms worsen.
Moderate exercise is generally safe and may improve overall health.
Yes, ongoing management is needed to monitor and control the disease.
Hope on the Horizon
While current treatments for PSC are limited, ongoing research offers hope for more effective therapies in the future.
References
- Lindor KD, et al. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015;110(5):646-659.
- Karlsen TH, et al. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67(6):1298-1323.
- Tabibian JH, et al. Medical management of primary sclerosing cholangitis in 2017. Curr Opin Gastroenterol. 2017;33(3):149-157.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
15-min consultation. No hidden costs.
AI Doctor Visit Required
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?